Narcyz Ghinea

436 total citations
48 papers, 249 citations indexed

About

Narcyz Ghinea is a scholar working on Economics and Econometrics, Physiology and General Health Professions. According to data from OpenAlex, Narcyz Ghinea has authored 48 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Economics and Econometrics, 16 papers in Physiology and 11 papers in General Health Professions. Recurrent topics in Narcyz Ghinea's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (16 papers) and Biomedical Ethics and Regulation (14 papers). Narcyz Ghinea is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (16 papers) and Biomedical Ethics and Regulation (14 papers). Narcyz Ghinea collaborates with scholars based in Australia, New Zealand and United States. Narcyz Ghinea's co-authors include Wendy Lipworth, Ian Kerridge, Richard O. Day, James M. van Gelder, Gregory J. Dore, Mark Danta, Andrew F. Hill, Miles Little, Christopher G. Maher and Cameron Stewart and has published in prestigious journals such as The Lancet, BMJ and Annals of Oncology.

In The Last Decade

Narcyz Ghinea

46 papers receiving 245 citations

Peers

Narcyz Ghinea
Hanneke Zwikker Netherlands
Anna Hung United States
Reem Alturki Switzerland
Richardae Araojo United States
Stefanie H. Mueller United Kingdom
Tara Kelley United States
Ann Abraham United States
Hanneke Zwikker Netherlands
Narcyz Ghinea
Citations per year, relative to Narcyz Ghinea Narcyz Ghinea (= 1×) peers Hanneke Zwikker

Countries citing papers authored by Narcyz Ghinea

Since Specialization
Citations

This map shows the geographic impact of Narcyz Ghinea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narcyz Ghinea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narcyz Ghinea more than expected).

Fields of papers citing papers by Narcyz Ghinea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narcyz Ghinea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narcyz Ghinea. The network helps show where Narcyz Ghinea may publish in the future.

Co-authorship network of co-authors of Narcyz Ghinea

This figure shows the co-authorship network connecting the top 25 collaborators of Narcyz Ghinea. A scholar is included among the top collaborators of Narcyz Ghinea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narcyz Ghinea. Narcyz Ghinea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ghinea, Narcyz, Katrina Hutchison, Mianna Lotz, & Wendy Rogers. (2024). Cost-Related Non-Adherence to Prescribed Medicines: What Are Physicians’ Moral Duties?. The American Journal of Bioethics. 25(8). 111–122. 1 indexed citations
3.
Ghinea, Narcyz. (2024). Cost barriers to medication access in Australia: an analysis of the Patient Experience Survey in context. The Medical Journal of Australia. 221(8). 414–416. 1 indexed citations
4.
Ghinea, Narcyz. (2024). The increasing costs of medicines and their implications for patients, physicians and the health system. Internal Medicine Journal. 54(4). 545–550. 3 indexed citations
5.
Ghinea, Narcyz. (2023). ‘First ensure no regret’: a decision-theoretic approach to informed consent in clinical practice. Journal of Medical Ethics. 51(11). 789–790. 1 indexed citations
7.
Ghinea, Narcyz, et al.. (2023). The incidence of personal importation of prescription medicines among Australians 45 and older: a cross-sectional survey. Australian Health Review. 47(6). 694–699. 4 indexed citations
8.
Ghinea, Narcyz, Wendy Lipworth, Ian Kerridge, & John Zalcberg. (2023). How therapeutic advances have transformed the medical landscape: a primer for clinicians. Internal Medicine Journal. 53(8). 1306–1310. 1 indexed citations
9.
Ghinea, Narcyz, et al.. (2022). Situating commercialization of assisted reproduction in its socio-political context: a critical interpretive synthesis. Human Reproduction Open. 2022(4). hoac052–hoac052. 5 indexed citations
10.
Ghinea, Narcyz, et al.. (2020). Are my religious beliefs anyone’s business? A framework for declarations in health and biomedicine. Journal of Medical Ethics. 47(12). 803–806. 2 indexed citations
11.
Ghinea, Narcyz, Christine Critchley, Ian Kerridge, et al.. (2020). A survey of Australian public attitudes towards funding of high cost cancer medicines. Health Policy. 125(3). 327–334. 4 indexed citations
12.
Ghinea, Narcyz, Wendy Lipworth, & Ian Kerridge. (2020). Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity?. Journal of Bioethical Inquiry. 17(1). 87–94. 2 indexed citations
13.
Lipworth, Wendy, Ian Kerridge, Narcyz Ghinea, & John Zalcberg. (2018). Clearing the air: towards agreement about access to high cost cancer medicines. Annals of Oncology. 30(1). 143–146. 2 indexed citations
14.
Ghinea, Narcyz, et al.. (2018). An ethical framework for the creation, governance and evaluation of accelerated access programs. Health Policy. 122(9). 984–990. 9 indexed citations
15.
Ghinea, Narcyz, Miles Little, & Wendy Lipworth. (2017). Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry—Defining the “Goods” at Stake. Journal of Bioethical Inquiry. 14(3). 401–410. 3 indexed citations
16.
Ghinea, Narcyz, et al.. (2017). Accelerated Access to Medicines: An Ethical Analysis. Therapeutic Innovation & Regulatory Science. 51(2). 157–163. 10 indexed citations
17.
Lipworth, Wendy, Narcyz Ghinea, & Ian Kerridge. (2016). NEGOTIATING LIMITS TO THE FUNDING OF HIGH COST CANCER MEDICINES. The Sydney eScholarship Repository (The University of Sydney). 40(2). 119–122. 2 indexed citations
18.
Day, Richard O., Wendy Lipworth, & Narcyz Ghinea. (2015). The Ethics Around Drug Labels and Generic Medicines. Therapeutic Innovation & Regulatory Science. 49(3). 348–351. 2 indexed citations
19.
Ghinea, Narcyz, Wendy Lipworth, Ian Kerridge, & Richard O. Day. (2012). No evidence or no alternative? Taking responsibility for off‐label prescribing. Internal Medicine Journal. 42(3). 247–251. 7 indexed citations
20.
Ghinea, Narcyz & James M. van Gelder. (2004). A probabilistic and interactive decision-analysis system for unruptured intracranial aneurysms. Neurosurgical FOCUS. 17(5). 1–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026